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Dysfunctions of the mitochondria and the ubiquitin–proteasome system, as well as generation of reactive
oxygen species (ROS), are linked tomany aging-related neurodegenerative disorders. However, the order of
these events remains unclear. Here, we show that the initial impairment occurs in mitochondria under
proteasome inhibition. Fluorescent redox probe measurements revealed that proteasome inhibition led to
mitochondrial oxidation followed by cytosolic oxidation, which could be prevented by a
mitochondrial-targeted antioxidant or antioxidative enzyme. These observations demonstrated that
proteasome dysfunction causes damage to mitochondria, leading them to increase their ROS production
and resulting in cytosolic oxidation. Moreover, several antioxidants found in foods prevented intracellular
oxidation and improved cell survival by maintaining mitochondrial membrane potential and reducing
mitochondrial ROS generation. However, these antioxidant treatments did not decrease the accumulation
of protein aggregates caused by inhibition of the proteasome. These results suggested that antioxidative
protection of mitochondria maintains cellular integrity, providing novel insights into the mechanisms of
cell death caused by proteasome dysfunction.
I
mpairment of the ubiquitin–proteasome system (UPS), mitochondrial dysfunction, and generation of reactive
oxygen species (ROS) have been strongly associated with cell death–mediated aging and the pathogenesis of
neurodegenerative disorders, e.g., Alzheimer’s and Parkinson’s disease1–3. However, the order in which these
events occur, as well as the intracellular mechanisms that connect proteasome and mitochondrial impairment,
remain unclear.
The UPS is a major protein degradation pathway that is essential for cellular protein homeostasis4. The UPS
eliminates misfolded or damaged proteins, which are selectively polyubiquitinated, recognized, and then
degraded by proteasomes. Over the course of aging, proteasomal activity declines as a result of decreased
expression and oxidative modification of proteasomal proteins5,6. Previous studies demonstrated that genetic
mutations in UPS components result in several rare familial neurodegenerative diseases, providing a direct link
between UPS dysfunction and neurodegeneration7,8. Accumulation of protein aggregates caused by proteasome
dysfunction is considered to be a hallmark of aging and the most likely cause of neurodegenerative diseases.
Proteasome inhibition leads to cell death; although the mechanism is incompletely understood, recent work has
suggested that a shortage of free amino acids (normally produced by proteasomal degradation) is one possible
cause of the cell death that occurs when the proteasome is inhibited9. Several reports have indicated that protein
aggregates can generate ROS through interactions with redox-active metal ions10–12. Although moderate levels of
ROS function as signals to promote cell proliferation and survival, excessive levels of ROS induce oxidative
modifications of proteins, thereby promoting protein aggregation13,14. Compounding the problem, oxidative
modifications of the proteasome reduce its stability and function, leaving it less able to remove protein
aggregates15,16.
Mitochondria fulfill a number of essential cellular functions. Although their primary role is generation of ATP
through oxidative phosphorylation, they also control programmed cell death, a key feature of neurodegenerative
diseases3,17. Mitochondria are also the major site of intracellular ROS production, which occurs via electron
leakage as a byproduct of ATP generation by oxidative phosphorylation. Mitochondrial antioxidative enzymes
such as manganese SOD (MnSOD) and glutathione peroxidase detoxify ROS, but excess ROS generation can
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susceptible to ROS: in particular, the components of the electron
transport chain (ETC) and mitochondrial DNA (mtDNA) are vul-
nerable to oxidative damage3,18. mtDNA has a 10-fold higher muta-
tion frequency relative to nuclear DNA19. Mitochondrial function is
impaired over the course of aging20,21, and injured mitochondria
produce higher levels of ROS via further electron leakage from the
impaired ETC. This vicious cycle leads to age-related accumulation
of ROS, inducing alterations in the mitochondrial genome and
generating oxidized proteins that cause further mitochondrial
dysfunction.
In this study, we investigated the changes that occur in the intra-
cellular redox state following induction of proteasome dysfunction
and assessed redox maintenance by redox modulators, by monitor-
ing the intracellular redox state using our newly developed redox
sensor probe, Redoxfluor22,23. Following proteasome inhibition, the
cytosolic milieu was in an oxidized state, but the normal redox state
could be restored by treating cells with two natural antioxidants,
resveratrol and sesamin, or with mitochondrial-targeted antioxi-
dants and antioxidative enzymes. Antioxidant treatments increased
cell viability, but did not decrease the level of protein aggregation.
Following proteasome inhibition, mitochondrial redox state was oxi-
dized (concomitant with the mitochondrial accumulation of ubiqui-
tinated proteins) before similar changes occurred in the cytosol.
Taken together, our results show that mitochondria are the primary
initial sites of oxidative damage following proteasome dysfunction.
Furthermore, antioxidative protection of mitochondria maintained
cellular integrity even in the presence of protein aggregates caused by
proteasome dysfunction.
Results
Inhibition of proteasome-mediated protein degradation leads to
intracellular oxidation. In order to assess the intracellular redox
state in cells after proteasome-inhibition, we used Chinese Hams-
ter Ovary (CHO) cells stably expressing the redox-sensing protein,
Redoxfluor22. Redoxfluor possesses tandem redox-sensing regions
derived from the yeast oxidative stress–responsive transcription
factor Yap1p, flanked by cerulean (CYP) and citrine (YFP), and
exhibits fluorescence resonance energy transfer (FRET) correspond-
ing to its redox-dependent structural change22. Redoxfluor directly
interacts with ROS and glutathione, and efficiently reacts with
thioredoxin in the presence of peroxiredoxin (Tsa1p)22,24; conse-
quently, it displays the integrated redox state as a FRET ratio.
Visualization of the FRET ratio under control conditions revealed
orange-colored areas in the cytosolic region (Fig. 1A, left panel). By
contrast, treatment with the proteasome inhibitor bortezomib for 8 h
changed the FRET ratio color from orange to yellow, indicating
oxidation of the cytosolic redox state. Bortezomib also dramatically
increased the level of polyubiquitinated proteins relative to the
control condition (Supplementary Fig. S1). Quantitation of the
FRET ratios confirmed the statistical significance of the result
(Fig. 1A, right panel).
Ubiquitination is one of the crucial steps of UPS, in which proteins
targeted for proteolysis are tagged with ubiquitin, leading to poly-
ubiquitination. Among the seven lysine residues in ubiquitin, Lys48
plays a vital role in polyubiquitination, and Lys48-linked polyubi-
quitination is a major signal for targeting of proteins to the protea-
some25. Therefore, mutation of the Lys48 residue to arginine (K48R)
interferes with the polyubiquitination of damaged proteins and their
proteasomal targeting. Overexpression of K48R HA-ubiquitin in
CHO cells lowered the FRET ratio of Redoxfluor, indicating that this
mutation had led to an oxidized redox state by inhibiting K48-linked
polyubiquitination. By contrast, overexpression of HA-ubiquitin did
not affect the FRET ratio (Fig. 1B).
To confirm the intracellular oxidization detected by Redoxfluor,
we examined the effect of proteasome inhibition by MG132 on the
glutathione redox state. The GSH/GSSG ratio was reduced after
treatment with the drug (Fig. 1C). Similarly, the intracellular fluor-
escence intensity of a ROS probe, CM-H2DCFDA, increased in the
presence of bortezomib orMG132, although the increase was slightly
lower than that observed upon the addition of H2O2 (Fig. 1D). It
remains controversial whether this probe can be used to measure
ROS production in cells26. Therefore, we also used the hydrogen
peroxide sensor HyPer to detect the increase of intracellular hydro-
gen peroxide under proteasome inhibition (Fig. 1E). Cytosolic HyPer
exhibited a substantial increase in the fluorescent ratio (Ex 500/420),
suggesting that MG132 treatment increased the level of H2O2 level.
These results demonstrated that impairment of the UPS led to intra-
cellular oxidation, reflected in both the GSH/GSSG ratio and the
levels of ROS (including H2O2).
Antioxidants, as redox modulators, counteract the intracellular
oxidation caused by proteasome inhibition.Next, we examined the
redox-modulating effect of the antioxidant resveratrol under
proteasome inhibition. CHO cells that were simultaneously treated
with bortezomib and resveratrol exhibited the same cytosolic orange
FRET image observed in control cells (Fig. 2A, left panel). The quan-
titated FRET ratio of cells treated with bortezomib and resveratrol
was higher than that of cells treated with the proteasome inhibitor
alone (Fig. 2A, right panel), indicating that resveratrol promoted
recovery from an oxidized state to a normal cytosolic redox state.
In addition, antioxidant treatment partially but significantly im-
proved the cell viability of both bortezomib-treated and MG132-
treated cells (Fig. 2B and Supplementary Fig. S2A).
In proteasome inhibitor–treated cells, intracellular production of
ROS, including H2O2, as detected by CM-H2DCFDA or HyPer, was
also suppressed by the addition of resveratrol (Fig. 2C and D and
Supplementary Fig. S2B), in accordance with the improved viability
of these cells. However, resveratrol did not remedy the oxidized
glutathione redox state (GSH/GSSG) (Fig. 2E), suggesting that intra-
cellular glutathione contributed to attenuation of intracellular ROS
levels even in the presence of resveratrol. Furthermore, resveratrol
did not decrease the accumulation of polyubiquitinated proteins in
the detergent-soluble and -insoluble fractions including protein
aggregates (Fig. 2F and G). Although Redoxfluor can also detect
the glutathione redox state22, it is more sensitive to the ROS level
than the glutathione redox state in the cytosol, resulting in an appar-
ent discrepancy in assessments of the redox state obtained using
glutathione redox state vs. Redoxfluor. Together, these data indicated
that resveratrol can function as a redox modulator to prevent ROS
production, maintain intracellular redox homeostasis, and promote
cell viability in the presence of proteasome inhibitors.
Another antioxidant, sesamin, exhibited similar effects on redox
maintenance and cell viability under proteasome inhibition (Supple-
mentary Fig. S3A and B). Although sesamin was less effective than
resveratrol in reducing cytosolic ROS levels in bortezomib-treated
cells, the reduction was statistically significant (Fig. 2C and Supple-
mentary Fig. S3C). By contrast to resveratrol and sesamin, ascorbic
acid did not serve as a redoxmodulator under proteasome inhibition
(Supplementary Fig. S4).
Proteasome inhibition causes a decrease in mitochondrial mem-
brane potential and an increase in mitochondrial ROS produc-
tion. The results described above indicated that proteasome
inhibition caused cytosolic oxidation (as detected by Redoxfluor)
and an increase in cytosolic and nuclear ROS levels (as detected by
HyPer). Because mitochondria are considered to be the major
intracellular source of ROS18, we investigated whether the observed
cytosolic oxidation was due to impaired mitochondria. Mitochond-
rial membrane potential, a consequence of the electrochemical
proton gradient maintained for the purpose of ATP synthesis, is an
important indicator of functional mitochondria. Therefore, we
monitored mitochondrial membrane potential in CHO cells under
proteasome inhibition using a mitochondrial-targeted probe,
www.nature.com/scientificreports
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Figure 1 | Proteasome and ubiquitination inhibition leads to cellular oxidation. FRET ratio images of CHO cells expressing Redoxfluor are shown (left
panels), and the FRET ratio is quantitated (right panels), (A) after 8 h treatment with 1 mMbortezomib (bort), and (B) 24 h after transfection with HA-
WT ubiquitin or K48R ubiquitin. (C) The ratio of GSH/GSSG after 8 h treatment with 10 mM MG132. (D) Fluorescence images (left panel) and
quantitation (right panel) of relative fluorescence intensity representing cytosolic ROS detection by CM-H2DCFDA and (E) cytosolic H2O2–dependent
fluorescence ratio of Hyper after 8 h treatment with the proteasome inhibitor bortezomib or MG132. H2O2 was used as a positive control. Quantitated
values are shown as means 6 s.e.m. of three independent measurements. **: p , 0.01, *: p , 0.05.
www.nature.com/scientificreports
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Figure 2 | Resveratrol functions as a redox modulator under proteasome inhibition. (A) FRET analysis of CHO cells expressing Redoxfluor.
Fluorescence images are shown (left panel) and the relative fluorescence intensity is quantitated (right panel). (B) Relative cell viability as determined by
theMTT assay. (C) Cytosolic ROS detection using CM-H2DCFDA. Fluorescence images are shown (upper panel), and fluorescence levels are quantitated
(lower panel). (D) Cytosolic H2O2 detection using Hyper. H2O2 (200 mM) was used as a positive control. (E) The ratio of GSH/GSSG, and (F, G)
immunoblotting of polyubiquitinated proteins with anti-ubiquitin in 1% NP-40–soluble (F) and -insoluble (G) CHO cell fractions. All treatments were
performed for 8 h: DMSO (control); 1 mMbortezomib (bort); 10 mMMG132; or simultaneous treatment with the proteasome inhibitors, bortezomib or
MG132, and 10 mM resveratrol (Res). Quantitated values are shown as themeans 6 s.e.m. of three independentmeasurements. **: p, 0.01, *: p, 0.05.
www.nature.com/scientificreports
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Mitotracker Red CMXRos, which accumulates in mitochondria
depending on its membrane potential. In cells treated with the
proteasome inhibitor alone, the fluorescence intensity of the probe
decreased, indicating a loss in mitochondrial membrane potential
(Fig. 3A). However, simultaneous treatment with the proteasome
inhibitor and resveratrol prevented the reduction in mitochondrial
membrane potential.
Next, we measured mitochondrial ROS production under protea-
some inhibition using MitoSOX Red, a fluorogenic superoxide-
detecting dye that specifically targets mitochondria. Proteasome
inhibition by bortezomib or MG132 led to increased production of
mitochondrial superoxide anion in CHO cells; a similar effect was
also caused by addition of rotenone, which increases mitochondrial
superoxide anion production by inhibiting complex I of the ETC
(Fig. 3B and C). Because these treatments resulted in loss of mito-
chondrial membrane potential, as shown in Fig. 3A, we interpret the
elevated concentration of mitochondrial superoxide anion under
proteasome inhibition as an indication of electron leaks from the
ETC. In bortezomib-treated cells, resveratrol effectively prevented
an increase in mitochondrial production of superoxide anion. A
similar effect was also detected using sesamin (Supplementary Fig.
S3D and E). Thus, resveratrol and sesamin reversed the effects of
proteasome inhibition–mediated intracellular oxidation by main-
taining membrane potential and preventing mitochondrial ROS
production.
Proteasome inhibition induces mitochondrial aberration prior to
cytosolic oxidation. The results described so far demonstrate that
proteasome inhibition causes mitochondrial damage, reflected by a
loss of membrane potential and mitochondrial ROS generation. To
uncover the relationship between mitochondrial damage and
proteasome inhibition, we examined mitochondrial accumulation
of polyubiquitinated proteins. Mitochondrial proteins that undergo
degradation by the UPS are released from the outer mitochondrial
membrane into the cytosol27–29, and proteasome inhibition causes
accumulation of ubiquitinated proteins in the outer mitochondrial
membrane30. Therefore, we monitored accumulation of polyubi-
quitinated protein in the light mitochondrial fraction (LMF),
which includes the outer mitochondrial membrane, following pro-
teasome inhibition. Polyubiquitinated proteins in the LMF were
sharply elevated 4 h after treatment with MG132, and gradually
increased further thereafter (Fig. 4A, left panel). We validated the
subcellular fractionation by detecting compartment-specific marker
proteins. The LMF was considerably enriched in an outer mito-
chondrial membrane marker protein, VDAC1, but did not contain
a peroxisome-localized catalase. However, low levels of ER-localized
ERp72 and cytosolic GAPDH were present as contaminants in the
LMF (Supplementary Fig. S6A). In the cytosolic fraction, polyubi-
quitinated proteins were elevated at 6 h after MG132 treatment, 2 h
later than these proteins accumulated in the LMF (Fig. 4A, right
panel). Furthermore, treatment with proteasome inhibitors in-
creased the proportion of HA-tagged ubiquitin co-localized on
mitochondria (detected using MitoTracker Deep Red), indicating
that polyubiquitinated proteins accumulated in the mitochondria
(Supplementary Fig. S6B). Under normal conditions, HA-tagged
ubiquitin was diffusely distributed throughout the cell, although
the concentration appeared to be somewhat elevated in the nucleus.
Next, we monitored the mitochondrial redox state following pro-
teasome inhibition using mitochondria-targeted roGFPs because we
could not prepare a functional construct of mitochondria-targeted
Redoxfluor so far. We assessed the redox state by ratiometric mea-
surement of roGFP fluorescence intensity excited at 405 and at
488 nm31,32. In this assay, a higher ratio (405/488 in roGFP1/the
cytosolic roGFP, 488/405 in roGFP2/the mitochondrial one) indi-
cated an oxidized state, whereas a lower ratio indicated a reduced
state. The mitochondrial redox state was oxidized 3–4 h after
MG132-treatment (Fig. 4B, left panel), coincident with the timing
of mitochondrial accumulation of polyubiquitinated proteins
(Fig. 4A). By contrast, the cytosolic redox state assessed using cyto-
solic roGFP was oxidized 5–6 h post-treatment, also coincident with
the timing of cytosolic accumulation of polyubiquitinated proteins
(Fig. 4A), which as noted above occurred later than the mitochon-
drial oxidation (Fig. 4B, right panel). Neither cytosolic nor mito-
chondrial redox states changed in the absence of proteasome
inhibition. These data indicated that proteasome inhibition caused
mitochondrial oxidation and accumulation of polyubiquitinated
proteins before similar changes occurred in the cytosol.
Mitochondrial ROS are responsible for the cytosolic oxidation
and cell death observed after proteasome inhibition. Proteasome
inhibition induced mitochondrial oxidation prior to cytosolic
oxidation, whereas the antioxidants derived from foods suppressed
cytosolic oxidation and cell death by maintaining mitochondrial
integrity and preventing ROS generation (Figs. 2–4). Thus, resver-
atrol appears to counter mitochondrial ROS production by acting as
an ROS scavenger, thereby maintaining the cytosolic redox state.
Resveratrol has been reported to function not only as a direct ROS
scavenger, but also as an inducer of antioxidant gene expression33. To
ascertain the mechanism by which resveratrol blocks the deleterious
consequences of proteasome inhibition, we examined the effect of
MitoQ, a mitochondrial-targeted antioxidant in which the ubiquinol
moiety of coenzyme Q is conjugated to a lipophilic triphenylpho-
sphonium that blocks mitochondrial ROS generation and preserves
mitochondrial function34, in proteasome-inhibited cells. In CHO
cells expressing Redoxfluor treated with MG132 exhibited a yellow
FRET image, similar to that observed in cells treatedwith bortezomib
(Fig. 5A and Fig. 1A). AlthoughMitoQ treatment alone did not affect
the FRET ratio of Redoxfluor in CHO cells, MitoQmaintained more
reduced conditions in MG132-treated cells. Similar to resveratrol or
sesamin treatment, MitoQ treatment also prevented mitochondrial
ROS generation, as detected by MitoSOX, and improved the cell
viability of MG132-treated cells as effectively as resveratrol (Fig. 5B
andC). These data indicated that, inMitoQ-treated cells, cell viability
and the cytosolic redox state recovered after proteasome inhibition
because mitochondrial ROS generation was prevented.
Next, we examined the effect of the expression of mitochondrial or
cytosolic SOD on redox state under proteasome inhibition. MnSOD,
which is exclusively localized in mitochondrial matrix, provides the
primarymitochondrial antioxidative defense against ROS35.MnSOD
overexpression increased the FRET ratio of Redoxfluor in MG132-
treated CHO cells relative to that of mock-transfected cells (Fig. 5D).
Overexpressed MnSOD co-localized with the specific mitochondrial
marker MitoTracker Deep Red (Supplementary Fig. S5B). By con-
trast, overexpression of SOD1, which is mainly localized in the cyto-
sol, had no significant effect on the FRET ratio of Redoxfluor in
MG132-treated CHO cells (Fig. 5E). The expression of transfected
SOD1was confirmed by immunostaining (Supplementary Fig. S5D).
Similar to redox modulators such as resveratrol and MitoQ, over-
expressed MnSOD restored cell viability, whereas overexpressed
SOD1 did not (Fig. 5F). These data suggested that suppression of
superoxide anions in mitochondria, not in the cytosol, maintains a
reduced cytosolic redox state under proteasome inhibition. Taken
together, these data demonstrate that proteasome inhibition caused
mitochondrial ROS generation followed by cytosolic oxidation, and
that suppression of ROS generation in mitochondria rescued both
the cytosolic redox state and cell viability.
Discussion
We used a newly developed redox sensor, Redoxfluor22, which was
stably expressed in CHO cells, to assess the intracellular redox state.
Redoxfluor integrates multiple different redox indicators: ROS, glu-
tathione, and thioredoxin22–24. In a previous study, we showed that a
www.nature.com/scientificreports
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peroxisome-deficient cell line had a reduced redox state relative to
the wild-type cell line22. In this study, we screened various conditions
and chemicals that changed the intracellular redox state and affected
cellular viability.Many previous studies have shown that proteasome
inhibition causes ROS generation and oxidization of the intracellular
glutathione redox state36–39. In addition, disturbance of the normal
polyubiquitination machinery causes abnormal protein degradation
associated with increased oxidative damage40,41. Redoxfluor enabled
us to visualize oxidation in the cytosol caused by inhibition of either
the proteasome or K48-linked polyubiquitination (Fig. 1A and B).
Furthermore, several redox modulators could return the oxidation
state to normal and could substantially rescue cellular viability,
although the glutathione redox state remained oxidized (Fig. 2 and
Supplementary Fig. S2). The physiological redox state, as represented
by the FRET ratio of Redoxfluor, correlated positively with cell
viability.
We revealed the sequential events following inhibition of the UPS
(Fig. 6). Mitochondrial impairment occurred soon after proteasome
inhibition, as judged by accumulation of polyubiquitinated proteins
in mitochondria, resulting in loss of mitochondrial membrane
potential and the generation of ROS, e.g., superoxide anion, from
the ETC. Mitochondrial superoxide anion is swiftly converted into
H2O2. Because the cytosolic redox capacity is larger than the mito-
chondrial one, H2O2 diffused into the cytosol were eliminated by
Figure 3 | Resveratrol protects mitochondrial membrane integrity and function in cells under proteasome inhibition. (A) Mitochondrial membrane
potential was detected using the mitochondrial membrane potential (Dym)-sensitive fluorochrome MitotrackerH Red CMXRos. (B, C) Mitochondrial
ROS were detected using the MitoSOX Red probe 8 h after treatment with bortezomib alone or bortezomib 1 resveratrol (B) or with MG132
alone or MG132 1 resveratrol (C). Fluorescence images are shown (left panels), and the relative fluorescence intensity is quantitated (right panels).
Rotenone was used as positive control. Quantitated values are shown as means 6 s.e.m. of three independent measurements. **: p , 0.01.
www.nature.com/scientificreports
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cytosolic antioxidant systems until the ROS levels generated bymito-
chondria exceeded the cytosolic redox defense. After that, mitochon-
dria-generated ROS caused oxidation in the cytosol, concomitant
with the decrease in cell viability. Thus, the delay in cytosolic oxida-
tion observed in Fig. 4B might be due to the high capacity of the
cytosolic antioxidant system. The sequence of events that occurred
after proteasome inhibition is supported by the following observa-
tions: i) Time-lapse detection of local redox changes and ubiquiti-
nated protein accumulation revealed that the mitochondrial redox
state was oxidized concomitant with mitochondrial accumulation of
polyubiquitinated proteins, prior to similar changes in the cytosol
(Fig. 4). ii) Mitochondrial-specific antioxidative treatments (MitoQ
treatment or MnSOD overexpression) suppressed mitochondrial
ROS generation and rescued the cytosolic redox state and cell viab-
ility (Fig. 5 and Supplementary Fig. S5C). However, mitochondrial
antioxidative treatments resulted in only partial rescue of cell viab-
ility, suggesting that proteasome inhibition causes cell death by
alternative mechanisms, e.g., failure of amino-acid recycling9.
Proteasome inhibition causes the accumulation of polyubiquiti-
nated protein aggregates, which is associated with aging and neuro-
degenerative diseases1,6,42. In neuronal mitochondria, proteasome
inhibition induces rapid accumulation of polyubiquitinated pro-
teins30, apparently resulting inmitochondrial impairment.We found
that the level of polyubiquitinated proteins in the LMF increased
suddenly, concomitant with mitochondrial oxidation, 3–4 h after
addition of the proteasome inhibitor; the increase of polyubiquiti-
nated proteins and oxidation were observed in the cytosol,2 h later
(Fig. 4A). Antioxidative treatments targeting the mitochondria
diminished mitochondrial ROS production, restored the cytosolic
redox state, and rescued cell viability; however, these antioxidative
treatments did not reduce the level of polyubiquitinated proteins
(Figs. 2, 3 and 5). Thus, under proteasome dysfunction, antioxidative
protection of mitochondria was sufficient to prevent cell death even
in the presence of accumulated polyubiquitinated proteins (Fig. 6).
Using proteasome-inhibited CHO-cells stably expressing Redox-
fluor, we screened various chemicals and treatment strategies for the
ability to return the cytosolic oxidative state to normal levels and
restore cell viability. Among the compounds that worked were
resveratrol and sesamin, which are found in many natural products
(Fig. 2 and Supplementary Fig. S3). Natural compounds such as these
have attracted a great deal of attention for their potential ability to
prevent neurodegenerative diseases and aging. Resveratrol and sesa-
min induce the expression of antioxidant enzymes via the activation
of the oxidative stress-responding transcription factor Nrf233,43–47, as
well as by inducing molecular chaperones48, thereby preventing the
accumulation of protein aggregates. However, our results showed
that resveratrol did not attenuate formation of protein aggregates,
but did restore the cytosolic redox state and substantially improved
Figure 4 | Proteasome inhibition inducesmitochondrial oxidation and ubiquitinated protein accumulation before cytosol is oxidized. (A) Time course
of accumulation of polyubiquitinated proteins in the light mitochondria fraction (LMF) and (B) time-lapse measurement of the redox state in the
mitochondria (left panels) and cytosol (right panels) using mitochondria or cytosolic-targeted roGFP after treatment with DMSO (control) or 10 mM
MG132. VDAC1, an outer membrane mitochondrial protein, was used as a mitochondrial loading control, and actin was used as a cytosolic loading
control.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5896 | DOI: 10.1038/srep05896 7
cell viability (Fig. 2). Although themechanism bywhich these natural
compounds function as redox modulators needs to be clarified in
more detail, we suspect that resveratrol primary acts as a ROS scav-
enger inmitochondria. Our data suggest that in general, these natural
compounds act as redox modulators in cell death caused by UPS
perturbation, which is related to aging and neurodegenerative
diseases.
In conclusion, mitochondrial dysfunction represents the onset of
critical events that happen after proteasome impairment, leading to
intracellular oxidative stress and eventually to cell death. Using the
Figure 5 | Antioxidative protection of mitochondria improves cytosolic oxidation under proteasome inhibition. (A, D, E) FRET ratio images of CHO
cells expressing Redoxfluor (left panel in A, upper panels in D, E) and quantitation of the FRET ratio (right panel in A, lower panels in D, E) in cells under
proteasome inhibition 8 h after treatment with 10 mMMG132, or after simultaneous treatment with 10 mMMG132 and 1 mMMitoQ (A), and 24 h after
transfection with (D) MnSOD and (E) SOD1. (C) Mitochondrial ROS detection using the MitoSOX Red probe. Fluorescence images are shown (left
panel), and the relative fluorescence intensity is quantitated (right panel). (B, F) Relative cell viability as determined by the MTT assay. Assay was
performed at 8 h after treatment with MG132 alone or MG132 1 MitoQ (B) at 24 h after the transfection (F). Quantitated values are shown as means 6
s.e.m. of three independent measurements. **: p , 0.01, *: p , 0.05, NS: not significant.
www.nature.com/scientificreports
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physiological redox sensor Redoxfluor, we found that resveratrol and
sesamin function as redox modulators to restore not only the intra-
cellular redox state but also cell viability after proteasome inhibition
(Fig. 2 and Supplementary Fig. S2). Meanwhile, antioxidative pro-
tection of mitochondria, including treatment with these natural
redox modulators, maintained cellular integrity under proteasome
inhibition in spite of the accumulation of protein aggregates (Fig. 6).
These novel insights into the mechanism of cell death caused by
proteasome dysfunction will lead to further advancements in under-
standing the molecular mechanisms governing aging and neurode-
generative disorders, some of which are caused by proteasome
dysfunction, in relationship to the subcellular redox state.
Methods
Cell culture, construction of plasmids, and transfection. CHO cells were grown in
Ham’s F-12 medium supplemented with 10% fetal bovine serum and antibiotics
(100 U/ml penicillin and 100 mg/ml streptomycin) under humidified air containing
7%CO2 at 37uC.MnSODand SOD1 expression plasmids were constructed as follows:
Total RNA was extracted from HeLa cells using an RNeasy Mini Kit (Qiagen, Tokyo,
Japan) and reverse-transcribed using ReverTraAce enzyme (TOYOBO, Osaka,
Japan). The resulting cDNA was used as a template for the amplification of MnSOD
(forward: 59-ATGTTGAGCCGGGCAGT-G-39, reverse: 59-TTACTTTTTGCAAG-
CCATGTATCTTTCAGTTACAT-39) and SOD1 (forward: 59-CCGGAATTCG-
CCACCATGTACCCATACGATGTTCCAGATTACGCTGCGACGA AGGCCG-
TG-39, reverse: 59- ATTTGCGGCCGCTTATTGGGCGATCCCAATTACA CC-39).
The PCR-amplified products were inserted into pCDNA 3.1. HA (hemagglutinin)-
tagged wild-type and K48R ubiquitin expression plasmids, as well as cytosolic
roGFP1 and mitochondrial-targeted roGFP2 were kindly provided by Dr. Kazuhiro
Nagata (Kyoto Sangyo University, Japan)49 and Dr. S. James Lemington (Oregon
University)31, respectively. The plasmid encoding cytosolic HyPer (pHyPer-cyto) was
obtained from Evrogen. Cells were transfected with plasmids using Lipofectamine
2000 (Invitrogen, Tokyo, Japan).
Reagents and antibodies. Bortezomib was purchased from Selleck Chemicals.
MG132, resveratrol, and sesamin were obtained from Wako Pure Chemical (Osaka,
Japan). MitoQ was a kind gift from Dr. Michael P. Murphy (MRC Mitochondrial
Biology Unit, Cambridge, UK). Anti-ubiquitin (Santa Cruz Biotechnology, Dallas,
TX), anti-MnSOD (Life Span BioSciences, Seattle, WA), anti-VDAC1 and anti-
catalase (both from Abcam, Cambridge, MA), anti-HA (Covance, Denver, PA), anti-
b-actin (Sigma-Aldrich, Tokyo, Japan), anti-GAPDH (Cell signaling technology,
Beverly,MA), and anti-ERp72 (Enzo Life Sciences, Farmingdale, NY) antibodies were
used for immunostaining.
FRET analysis using Redoxfluor, measurement of cytosolic hydrogen peroxide
using HyPer, and measurement of redox state using roGFP. FRET measurements
were performed as previously described22. Fluorescence images of Redoxfluor, HyPer,
and roGFP were acquired using an IX70 fluorescence microscope (Olympus, Tokyo,
Japan) equipped with a CoolSNAP HQ2 CCD camera (Photometrics, Tucson, AZ).
HyPer and roGFP fluorescence was excited using the XF1076 filter (400AF30, Omega
Optical, Brattleboro, VT) for excitation of the peak around 420 nm (400 nm for
roGFP), and the U-MNIBA cube (BP 470–490, Olympus) for excitation of the peak
around 500 nm (480 nm for roGFP); the corresponding YFP and GFP emissions
were observed using the U-MNIBA cube (BP 515–550), respectively. Acquired
images were analyzed using the MetaMorph imaging software (Universal Imaging
Corp., Downingtown, PA).
Quantitation of intracellular glutathione by LC-MS. Intracellular glutathione
measurements were performed as previously described24. Briefly, a chilled methanol
extraction of cells was freeze-dried and resuspended in 1% acetonitrile, and then
applied to a Hydrosphere C18 column (YMC) on a Prominence nano HPLC system
(Shimadzu, Kyoto, Japan) in line with a 4000 QTRAP mass spectrometer (AB Sciex
Instruments, Foster City, CA).
MTT assay. Cells were grown in a 96-well microplate for 24 h, and then incubated
with 5 mg/mlMTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
for 4 h at 37uC (Nacalai Tesque, Kyoto, Japan). Next, 100 ml of solubilization solution
(isopropanol with 0.04 mol/l HCl) was added to dissolve precipitated formazans. The
plate was sealed and incubated overnight in a humidified chamber at 37uC; the next
day, absorbance was read at 570 nm. Relative cell numbers were expressed as a
percentage of untreated controls.
Fluorescence microscopy. All confocal fluorescence images were obtained
using an LSM 510 META confocal microscope (Carl Zeiss, Tokyo, Japan). For
detection of mitochondrial membrane potential and ROS, cells were labeled
at 37uC for 10 min (30 min for CM-H2DCFDA (5-(and-6)-chloromethyl-29,79-
dichlorodihydrofluorescein diacetate, acetyl ester)) with the following fluorescent
probes: 0.4 mM MitotrackerH Red CMXRos (chloromethyl-X-rosamine), 5 mM
MitoSOX Red probe, or 10 mM CM-H2DCFDA. After the incubation, these
fluorescent probes were washed out with Hank’s balanced salt solution. ImageJ was
used to quantitate fluorescence intensity. For immunocytochemistry, cells
overexpressing MnSOD were stained with Mitotracker Deep Red for 30 min in the
dark, and then fixed with 4% paraformaldehyde at room temperature (r.t.) for
20 min. Cells were permeabilized with 0.2% Triton X-100 for 10 min at r.t., and then
incubated in blocking buffer (1% glycerol, 1% bovine serum albumin, 1% goat serum,
and 0.2% Triton X-100) for 1 h. Cells were incubated with a rabbit anti-rat MnSOD
antibody for 2 h, and then with an Alexa Fluor 488–conjugated goat anti-rabbit IgG
secondary antibody for 1 h. All fluorescent probes were obtained from Invitrogen.
Mitochondrial fractionation. Cells were resuspended in homogenization medium
(HM) (0.25 M sucrose, 1 mM EDTA, 20 mM HEPES-NaOH [pH 7.4]) and
Figure 6 | Mitochondrial integrity is essential for preventing cytosolic oxidative stress caused by proteasome inhibition. The cytosol is normally
maintained in a reducing state (left panel). Proteasomal dysfunction first damagesmitochondrial integrity; then, the resulting ROS produced by impaired
mitochondria lead to cytosolic oxidation, and eventually to cell death (middle panel). Reversal of mitochondrial oxidation by redox modulators,
e.g., resveratrol and antioxidative enzymes, prevents cytosolic oxidation and eventual cell death without reducing the level of protein aggregation in cells
under proteasome inhibition (right panel).
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homogenized by gently passing the sample 10 times through a 25-gauge needle. The
homogenate was centrifuged at 1,0003 g and then the carefully removed supernatant
was centrifuged at 3,000 3 g. Crude light mitochondria fraction (LMF) was prepared
by centrifuging the resultant supernatant at 17,000 3 g for 15 min. Crude LMF was
further purified by 19–27% continuous ioxadiol density-gradient ultracentrifugation
in a swinging-bucket rotor at approximately 167,000 3 g for 2 h at 4uC.
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